Connection

Wei Wang to Immunity, Humoral

Back to Details
This is a "connection" page, showing publications Wei Wang has written about Immunity, Humoral.
Wei Wang
Connection Strength
0.018
Immunity, Humoral
  1. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 06 13; 395(10240):1845-1854.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.